NASDAQ:ESLA

Estrella Immunopharma, Inc.

Company facts

Most recent report
8-K, filed Sep 8, 2026
Filings on record
255 filings
On EDGAR
CIK 1844417
Fiscal year ends
December
Filer status
Emerging growth company

Financials 8 of 21

News 8 of 63

Prospectuses and Registrations 8 of 45

Proxies 7

Ownership 8 of 49

Other 8 of 70

Everything here comes from Estrella Immunopharma, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.